Reports for EMTRICITABINE

Active Ingredient

EMTRICITABINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2017-09-27 2017-10-02 23663
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2018-03-05 2018-03-20 41868
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-04-04 2019-05-21 80530
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2018-04-27 2019-06-19 47356
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Anticipated shortage 2019-06-25 2019-06-25 87463
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Avoided shortage 2017-09-22 2018-12-19 23172
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-01-02 2019-03-29 70748
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-04-03 2019-04-23 80423
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Actual shortage 2019-04-23 2019-06-25 82201
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports